These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 7842431)

  • 21. Detection of tumor progression in optic pathway glioma with and without neurofibromatosis type 1.
    Kelly JP; Weiss AH
    Neuro Oncol; 2013 Nov; 15(11):1560-7. PubMed ID: 24101736
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Delineation of the visual pathway in paediatric optic pathway glioma patients using probabilistic tractography, and correlations with visual acuity.
    Hales PW; Smith V; Dhanoa-Hayre D; O'Hare P; Mankad K; d'Arco F; Cooper J; Kaur R; Phipps K; Bowman R; Hargrave D; Clark C
    Neuroimage Clin; 2018; 17():541-548. PubMed ID: 29527480
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Optic glioma in children with type 1 neurofibromatosis].
    Ben-Arush M; Goldberg H; Kuten A; Guilbord J; el-Hassid R
    Harefuah; 1998 Oct; 135(7-8):264-7, 336. PubMed ID: 9885670
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Visual loss in orbitofacial neurofibromatosis type 1.
    Oystreck DT; Morales J; Chaudhry I; Alorainy IA; Elkhamary SM; Pasha TM; Bosley TM
    Ophthalmology; 2012 Oct; 119(10):2168-73. PubMed ID: 22709421
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Visual-evoked responses in children with optic gliomas, with and without neurofibromatosis.
    Cohen ME; Duffner PK
    Childs Brain; 1983; 10(2):99-111. PubMed ID: 6404610
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Optic nerve tortuosity in children with neurofibromatosis type 1.
    Ji J; Shimony J; Gao F; McKinstry RC; Gutmann DH
    Pediatr Radiol; 2013 Oct; 43(10):1336-43. PubMed ID: 23636538
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Visual outcomes after chemotherapy for optic pathway glioma in children with and without neurofibromatosis type 1: results of the International Society of Paediatric Oncology (SIOP) Low-Grade Glioma 2004 trial UK cohort.
    Falzon K; Drimtzias E; Picton S; Simmons I
    Br J Ophthalmol; 2018 Oct; 102(10):1367-1371. PubMed ID: 29343527
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Visual outcome of a cohort of children with neurofibromatosis type 1 and optic pathway glioma followed by a pediatric neuro-oncology program.
    Dalla Via P; Opocher E; Pinello ML; Calderone M; Viscardi E; Clementi M; Battistella PA; Laverda AM; Da Dalt L; Perilongo G
    Neuro Oncol; 2007 Oct; 9(4):430-7. PubMed ID: 17704361
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Optic gliomas in neurofibromatosis type 1 (NF-1). Presentation of 31 cases.
    Pascual-Castroviejo I; Martínez Bermejo A; López Martín V; Roche C; Pascual Pascual SI
    Neurologia; 1994 May; 9(5):173-7. PubMed ID: 8024821
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The role of visual electrodiagnostics in management of children with neurofibromatosis type 1.
    Tekavčič Pompe M; Pečarič Meglič N; Šuštar Habjan M
    Doc Ophthalmol; 2023 Apr; 146(2):121-136. PubMed ID: 36652041
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Optic glioma with abundant Rosenthal fibers associated with von Recklinghausen's disease--a case report].
    Aoki H; Ogashiwa M; Saito Y; Wakutani K
    No To Shinkei; 1970 Nov; 22(11):1313-8. PubMed ID: 4990899
    [No Abstract]   [Full Text] [Related]  

  • 32. Visual evoked potentials in children with neurofibromatosis type 1.
    Iannaccone A; McCluney RA; Brewer VR; Spiegel PH; Taylor JS; Kerr NC; Pivnick EK
    Doc Ophthalmol; 2002 Jul; 105(1):63-81. PubMed ID: 12152804
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Do visual evoked potentials give relevant information to the neuro-ophthalmological examination in optic nerve lesions?
    Nikoskelainen E; Falck B
    Acta Neurol Scand; 1982 Jul; 66(1):42-57. PubMed ID: 7113679
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The value of visual evoked potential as a screening test in neurofibromatosis.
    Jabbari B; Maitland CG; Morris LM; Morales J; Gunderson CH
    Arch Neurol; 1985 Nov; 42(11):1072-4. PubMed ID: 3931615
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Monitoring of optic nerve function in Neurofibromatosis 2 children with optic nerve sheath meningiomas using multifocal visual evoked potentials.
    Jayanetti V; Klistorner AI; Graham SL; Dexter M; Flaherty MP; Jones K; Billson FA; Wilson M; North K; Grigg JR; Fraser CL
    J Clin Neurosci; 2018 Apr; 50():262-267. PubMed ID: 29398196
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Spontaneous regression of optic glioma in a patient with neurofibromatosis.
    Brzowski AE; Bazan C; Mumma JV; Ryan SG
    Neurology; 1992 Mar; 42(3 Pt 1):679-81. PubMed ID: 1549238
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ophthalmological examination in neurofibromatosis type 1: a long-term retrospective analysis.
    Cassiman C; Laenen A; Jacobs S; Demaerel P; Legius E; Casteels I
    Acta Ophthalmol; 2018 Dec; 96(8):e1044-e1046. PubMed ID: 30259655
    [No Abstract]   [Full Text] [Related]  

  • 38. Pathological features of optic nerve and chiasmatic gliomas.
    Rubinstein LJ
    Neurofibromatosis; 1988; 1(3):152-8. PubMed ID: 3152462
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Magnetic resonance imaging signs of optic nerve gliomas in neurofibromatosis 1.
    Imes RK; Hoyt WF
    Am J Ophthalmol; 1991 Jun; 111(6):729-34. PubMed ID: 1903904
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Long-term visual outcomes of optic pathway gliomas in pediatric patients without neurofibromatosis type 1.
    Wan MJ; Ullrich NJ; Manley PE; Kieran MW; Goumnerova LC; Heidary G
    J Neurooncol; 2016 Aug; 129(1):173-8. PubMed ID: 27311725
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.